Skip to main content

Specimen Collection Manual and Test Catalog

  or
  or
  or

PROLACTIN, DILUTION STUDY

Geisinger Epic Procedure Code:  LAB1302    Geisinger Epic ID:  53133

SPECIMEN COLLECTION
Specimen type: 

Plasma or serum


Specimen required: 

2 mL of serum or plasma; minimum 1.5 mL.


Patient preparation: 

Eight-hour fasting is preferred. For premenopausal women, collection in early follicular cycle (before day 10) is recommended. In addition, no nipple stimulation or intercourse 24 hours prior to lab collection.



SPECIMEN PROCESSING
Processing instructions: 

Allow serum to clot. Centrifuge to separate serum or plasma within 2 hours of collection.


Transport temperature: 

Refrigerated (preferred) or frozen.


Specimen stability: 

Refrigerated: 14 days. Frozen: 6 months.


Rejection criteria: 

Stability limits exceeded.



TEST DETAILS
Reference interval: 

Females 0 to 55 years: 4.8-30 ng/mL 
Females > 55 years: 4.0-20 ng/mL
Males: 4.0-20 ng/mL


Additional information: 

HAMA (Human Anti-Mouse Antibodies) interfere with this test. Patients who have been treated with Mouse Monoclonal Antibodies should not be tested with this procedure.


CPT code(s):  84146
Note: The billing party has sole responsibility for CPT coding.  Any questions regarding coding should be directed to the payer being billed.
The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only.

Test includes: 

Prolactin. Dilutions of 10-fold and 100-fold are performed but not reported. The prolactin results obtained from these dilutions are compared to the neat result. Analytical artifacts are ruled out if the bias is within 20%.


Methodology: 
Roche Electrochemiluminescence Immunoassay. Patient results determined by assays using different manufacturers or methods may not be comparable.
Synonyms: 

PROLDS


Clinical significance: 

Prolactin-secreting macroadenomas may produce markedly high prolactin levels, causing an analytical artifact that results in underestimated prolactin measurements. This test is useful for patients exhibiting symptoms of prolactinoma due to the presence of a pituitary tumor, especially when initial prolactin studies show unexpectedly low results. The test incorporates dilution studies to detect and eliminate the analytical artifact.


Doctoral Director(s): 
Hoi-Ying Elsie Yu, PhD, DABCC, FADLM
Sheng-Ying (Margaret) Lo, PhD, DABCC
Review Date:  05/05/2025

Performing Locations